tradingkey.logo
tradingkey.logo
Search

Clarivate PLC

CLVT
Add to Watchlist
2.130USD
0.0000.00%
Close 06/26, 16:00ETQuotes delayed by 15 min
1.36BMarket Cap
LossP/E TTM

More Details of Clarivate PLC Company

Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.

Clarivate PLC Info

Ticker SymbolCLVT
Company nameClarivate PLC
IPO dateOct 29, 2018
CEOTov (Matitiahu Shem)
Number of employees12000
Security typeOrdinary Share
Fiscal year-endOct 29
Address70 St. Mary Axe
CityLONDON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited Kingdom
Postal codeEC3A 8BE
Phone442074334000
Websitehttps://clarivate.com/
Ticker SymbolCLVT
IPO dateOct 29, 2018
CEOTov (Matitiahu Shem)

Company Executives of Clarivate PLC

Name
Name/Position
Position
Shareholding
Change
Mr. Kenneth L. Cornick
Mr. Kenneth L. Cornick
Director
Director
1.20M
+4.68%
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
677.02K
+32.63%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
357.32K
+10.97%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
231.66K
-8.59%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
170.60K
+31.70%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
160.71K
+36.65%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+36.67%
Mr. Anthony Munk
Mr. Anthony Munk
Lead Independent Director
Lead Independent Director
--
--
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kenneth L. Cornick
Mr. Kenneth L. Cornick
Director
Director
1.20M
+4.68%
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
677.02K
+32.63%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
357.32K
+10.97%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
231.66K
-8.59%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
170.60K
+31.70%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
160.71K
+36.65%

FAQs

Who are the top five shareholders of Clarivate PLC?

The top five shareholders of Clarivate PLC are: Mr. Kenneth L. Cornick

How many institutions hold shares of Clarivate PLC (CLVT)?

As of 2026Q1, 545 institutions hold shares of Clarivate PLC, with a combined market value of approximately 574.46M, accounting for 89.87% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -98628183.00.

What is the biggest source of revenue for Clarivate PLC?

In 2026Q1, the Subscription revenues business generated the highest revenue for Clarivate PLC, amounting to 1.61B and accounting for 65.39% of total revenue.
KeyAI